Skip to main content

Articles

Page 4 of 92

  1. Chronic spinal cord injury (SCI) can lead to an insidious decline in motor and sensory function in individuals even years after the initial injury and is accompanied by a slow and progressive cytoarchitectural...

    Authors: Milan Radojicic, Gabriel Nistor and Hans S Keirstead
    Citation: BMC Neurology 2007 7:30
  2. Assessment of subjective quality of life (QOL) of persons with multiple sclerosis (MS) could facilitate the detection of psychosocial aspects of disease that may otherwise go unrecognized. The objectives of th...

    Authors: Asmahan F Alshubaili, Abdel W Awadalla, Jude U Ohaeri and Asser A Mabrouk
    Citation: BMC Neurology 2007 7:31
  3. There is a paucity of clinical studies focused specifically on intracerebral haemorrhages of subcortical topography, a subject matter of interest to clinicians involved in stroke management. This single centre...

    Authors: Adrià Arboix, Raquel Rodríguez-Aguilar, Montserrat Oliveres, Emili Comes, Luis García-Eroles and Joan Massons
    Citation: BMC Neurology 2007 7:32
  4. Interruption of flow through of cerebral blood vessels results in acute ischemic stroke. Subsequent breakdown of the blood brain barrier increases cerebral injury by the development of vasogenic edema and seco...

    Authors: Adviye Ergul, Mostafa M Elgebaly, Mary-Louise Middlemore, Weiguo Li, Hazem Elewa, Jeffrey A Switzer, Christiana Hall, Anna Kozak and Susan C Fagan
    Citation: BMC Neurology 2007 7:33
  5. Mental practice as an additional cognitive therapy is getting increased attention in stroke rehabilitation. A systematic review shows some evidence that several techniques in which movements are rehearsed ment...

    Authors: Susy M Braun, Anna J Beurskens, Susanne M van Kroonenburgh, Jeroen Demarteau, Jos M Schols and Derick T Wade
    Citation: BMC Neurology 2007 7:34
  6. Advanced glycation end-products (AGEs) and their receptor (RAGE) occur in dementia of the Alzheimer's type and diabetic microvascular disease. Accumulation of AGEs relates to risk factors for vascular dementia...

    Authors: Louise Southern, Jonathan Williams and Margaret M Esiri
    Citation: BMC Neurology 2007 7:35
  7. The presence of antiphospholipid antibodies (APLA) in multiple sclerosis (MS) patients has been reported frequently but no clear relationship between APLA and the clinical and neuroimaging features of MS have ...

    Authors: Carlos J Bidot, Lawrence L Horstman, Wenche Jy, Joaquin J Jimenez, Carlos Bidot Jr, Yeon S Ahn, J Steven Alexander, Eduardo Gonzalez-Toledo, Roger E Kelley and Alireza Minagar
    Citation: BMC Neurology 2007 7:36
  8. Neuroserpin, primarily localized to CNS neurons, inhibits the adverse effects of tissue-type plasminogen activator (tPA) on the neurovascular unit and has neuroprotective effects in animal models of ischemic s...

    Authors: John W Cole, Adam C Naj, Jeffrey R O'Connell, Oscar C Stine, John D Sorkin, Marcella A Wozniak, Barney J Stern, Manuel Yepes, Daniel A Lawrence, Laurie J Reinhart, Dudley K Strickland, Braxton D Mitchell and Steven J Kittner
    Citation: BMC Neurology 2007 7:37
  9. The pathological processes underlying dementia are poorly understood and so are the markers which identify them. Carnosinase is a dipeptidase found almost exclusively in brain and serum. Carnosinase and its su...

    Authors: Cynthia M Balion, Carolyn Benson, Parminder S Raina, Alexandra Papaioannou, Christopher Patterson and Afisi S Ismaila
    Citation: BMC Neurology 2007 7:38
  10. Locomotor training using body weight support and a treadmill as a therapeutic modality for rehabilitation of walking post-stroke is being rapidly adopted into clinical practice. There is an urgent need for a w...

    Authors: Pamela W Duncan, Katherine J Sullivan, Andrea L Behrman, Stanley P Azen, Samuel S Wu, Stephen E Nadeau, Bruce H Dobkin, Dorian K Rose and Julie K Tilson
    Citation: BMC Neurology 2007 7:39
  11. Complaints of unrefreshing sleep are a prominent component of chronic fatigue syndrome (CFS); yet, polysomnographic studies have not consistently documented sleep abnormalities in CFS patients. We conducted th...

    Authors: Matthias Majer, James F Jones, Elizabeth R Unger, Laura Solomon Youngblood, Michael J Decker, Brian Gurbaxani, Christine Heim and William C Reeves
    Citation: BMC Neurology 2007 7:40
  12. Mutations in the genes PRKN and LRRK2 are the most frequent known genetic lesions among Parkinson's disease patients. We have previously reported that in the Portuguese population the LRRK2 c.6055G > A; p.G2019S ...

    Authors: Jose Bras, Rita Guerreiro, Maria Ribeiro, Ana Morgadinho, Cristina Januario, Margarida Dias, Ana Calado, Cristina Semedo, Catarina Oliveira, John Hardy and Andrew Singleton
    Citation: BMC Neurology 2008 8:1
  13. The use of self-report measurements in clinical settings is increasing. However, in patients with limitations that interfere with reliable self-assessment such as cognitive impairment or mood disturbances, as ...

    Authors: Femke AH van der Linden, Jolijn J Kragt, Margarethe van Bon, Martin Klein, Alan J Thompson, Henk M van der Ploeg, Chris H Polman and Bernard MJ Uitdehaag
    Citation: BMC Neurology 2008 8:2
  14. A software based tool has been developed (Optem) to allow automatize the recommendations of the Canadian Multiple Sclerosis Working Group for optimizing MS treatment in order to avoid subjective interpretation.

    Authors: Juan Luís Ruiz-Peña, Pablo Duque and Guillermo Izquierdo
    Citation: BMC Neurology 2008 8:3
  15. The main objective of this study was to investigate the angiotensin converting enzyme (ACE) genotype as a possible risk factor for migraine (both with and without aura) compared to controls. We also wanted to exa...

    Authors: Erling Tronvik, Lars J Stovner, Gunnar Bovim, Linda R White, Amanda J Gladwin, Kathryn Owen and Harald Schrader
    Citation: BMC Neurology 2008 8:4
  16. In Spain, stroke is one of the major causes of death and the main cause of severe disability in people over 65 years. We analyzed the incidence of ischemic stroke, stroke subtypes, case fatality and disability...

    Authors: María Teresa Alzamora, Marta Sorribes, Antonio Heras, Nicolás Vila, Marisa Vicheto, Rosa Forés, José Sánchez-Ojanguren, Amparo Sancho and Guillem Pera
    Citation: BMC Neurology 2008 8:5
  17. Pesticides and correlated lifestyle factors (e.g., exposure to well-water and farming) are repeatedly reported risk factors for Parkinson's disease (PD), but few family-based studies have examined these relati...

    Authors: Dana B Hancock, Eden R Martin, Gregory M Mayhew, Jeffrey M Stajich, Rita Jewett, Mark A Stacy, Burton L Scott, Jeffery M Vance and William K Scott
    Citation: BMC Neurology 2008 8:6
  18. Over 50% of patients with upper limb paresis resulting from stroke face long-term impaired arm function and ensuing disability in daily life. Unfortunately, the number of effective treatments aimed at improvin...

    Authors: Jeanine A Verbunt, Henk AM Seelen, Feljandro P Ramos, Bernard HM Michielsen, Wim L Wetzelaer and Martine Moennekens
    Citation: BMC Neurology 2008 8:7
  19. Recent pathological studies have suggested that thalamic degeneration may represent a site of non-dopaminergic degeneration in Parkinson's Disease (PD). Our objective was to determine if changes in the thalami...

    Authors: Martin J McKeown, Ashish Uthama, Rafeef Abugharbieh, Samantha Palmer, Mechelle Lewis and Xuemei Huang
    Citation: BMC Neurology 2008 8:8
  20. The objective of this study was to analyze factors influencing the risk and timing of Alzheimer's disease (AD) in central Norway. The APOE ε4 allele is the only consistently identified risk factor for late onset ...

    Authors: Sigrid B Sando, Stacey Melquist, Ashley Cannon, Michael L Hutton, Olav Sletvold, Ingvild Saltvedt, Linda R White, Stian Lydersen and Jan O Aasly
    Citation: BMC Neurology 2008 8:9
  21. Neuroleptic-induced movement disorders (NIMDs) have overlapping co-morbidity. Earlier studies have described typical clinical movement patterns for individual NIMDs. This study aimed to identify specific movem...

    Authors: Sven Janno, Matti M Holi, Katinka Tuisku and Kristian Wahlbeck
    Citation: BMC Neurology 2008 8:10
  22. The EVIDENCE (EVidence of Interferon Dose-response: European North American Comparative Efficacy) study was an international, randomized, open-label, assessor-blinded, parallel-group study assessing the effica...

    Authors: A Traboulsee, A AL-Sabbagh, R Bennett, P Chang and DKB Li
    Citation: BMC Neurology 2008 8:11
  23. The relationship between stroke risk and cognitive function has not previously been examined in a large community living sample other than the Framingham cohort. The objective of this study was to examine the ...

    Authors: David J Llewellyn, Iain A Lang, Jing Xie, Felicia A Huppert, David Melzer and Kenneth M Langa
    Citation: BMC Neurology 2008 8:12
  24. Botulism is a rare disease caused by intoxication leading to muscle weakness and rapidly progressive dysphagia. With adequate therapy signs of recovery can be observed within several days. In the last few year...

    Authors: Inga K Teismann, Olaf Steinstraeter, Tobias Warnecke, Julian Zimmermann, Erich B Ringelstein, Christo Pantev and Rainer Dziewas
    Citation: BMC Neurology 2008 8:13
  25. Many individuals afflicted with multiple sclerosis (MS) experience a transient worsening of symptoms when body temperature increases due to ambient conditions or physical activity. Resulting symptom exacerbati...

    Authors: Dennis A Grahn, Julie vLS Murray and H Craig Heller
    Citation: BMC Neurology 2008 8:14
  26. Cognitive decline is a major threat to well being in later life. Change scores and regression based models have often been used for its investigation. Most methods used to describe cognitive decline assume ind...

    Authors: Graciela Muniz Terrera, Fiona Matthews and Carol Brayne
    Citation: BMC Neurology 2008 8:16
  27. Although stroke is a leading cause of morbidity and mortality in Nigeria, there is no information on awareness of its warning signs. This study was designed to assess awareness of stroke warning signs in Niger...

    Authors: Kolawole W Wahab, Peter O Okokhere, Asuwemhe J Ugheoke, Ojeh Oziegbe, Adedayo F Asalu and Taofeek A Salami
    Citation: BMC Neurology 2008 8:18
  28. The Paul Coverdell National Acute Stroke Registry (PCNASR) is a U.S. based national registry designed to monitor and improve the quality of acute stroke care delivered by hospitals. The registry monitors care ...

    Authors: Mathew J Reeves, Andrew J Mullard and Susan Wehner
    Citation: BMC Neurology 2008 8:19
  29. Hallucinations occur in 20–40% of PD patients and have been associated with unfavorable clinical outcomes (i.e., nursing home placement, increased mortality). Hallucinations, like other non-motor features of P...

    Authors: Spiridon Papapetropoulos, Heather Katzen, Anette Schrag, Carlos Singer, Blake K Scanlon, Daniel Nation, Alexandra Guevara and Bonnie Levin
    Citation: BMC Neurology 2008 8:21
  30. This study evaluated the benefits and impact of ICU therapeutic interventions on the survival and functional ability of severe cerebrovascular accident (CVA) patients.

    Authors: Moussa Riachy, Frida Sfeir, Ghassan Sleilaty, Samer Hage-Chahine, Georges Dabar, Taha Bazerbachi, Zeina Aoun-Bacha, Georges Khayat and Salam Koussa
    Citation: BMC Neurology 2008 8:24
  31. Medication nonadherence can be as high as 50% and results in suboptimal patient outcomes. Stroke patients in particular can benefit from pharmacotherapy for thrombosis, hypertension, and dyslipidemia but are a...

    Authors: Heather L Lummis, Ingrid S Sketris, Gordon J Gubitz, Michel R Joffres and Gordon J Flowerdew
    Citation: BMC Neurology 2008 8:25
  32. Hyperhomocysteinemia is a potentially modifiable risk factor for stroke, and may have a negative impact on the course of ischaemic stroke. The role of hyperhomocysteinemia as it relates to stroke in Africans i...

    Authors: Njideka U Okubadejo, Olajumoke O Oladipo, Adekunle A Adeyomoye, Gbolahan O Awosanya and Mustapha A Danesi
    Citation: BMC Neurology 2008 8:26
  33. Early feeding via a nasogastric tube (NGT) is recommended as safe way of supplying nutrition in patients with acute dysphagic stroke. However, preliminary evidence suggests that NGTs themselves may interfere w...

    Authors: Rainer Dziewas, Tobias Warnecke, Christina Hamacher, Stefan Oelenberg, Inga Teismann, Christopher Kraemer, Martin Ritter, Erich B Ringelstein and Wolf R Schaebitz
    Citation: BMC Neurology 2008 8:28
  34. Duloxetine hydrochloride is a reuptake inhibitor of 5-hydroxytryptamine and norepinephrine used to treat depression, generalized anxiety disorder, neuropathic pain, and stress incontinence in women. We investi...

    Authors: Asquad Sultan, Helen Gaskell, Sheena Derry and R Andrew Moore
    Citation: BMC Neurology 2008 8:29
  35. Genetic and environmental factors have important roles in multiple sclerosis (MS) susceptibility. A clear parent of origin effect has been shown in several populations, perhaps resulting from factors operating...

    Authors: Sreeram V Ramagopalan, William Valdar, David A Dyment, Gabriele C DeLuca, Sarah-Michelle Orton, Irene M Yee, Maria Criscuoli, George C Ebers and A Dessa Sadovnick
    Citation: BMC Neurology 2008 8:30
  36. Several studies have suggested that the specific stroke subtype may influence the presence of leukoaraiosis in patients with ischemic stroke. We investigated the association between stroke subtype and leukoara...

    Authors: Seung-Jae Lee, Joong-Seok Kim, Kwang-Soo Lee, Jae-Young An, Woojun Kim, Yeong-In Kim, Bum-Soo Kim and So-Lyung Jung
    Citation: BMC Neurology 2008 8:31
  37. Frontotemporal lobar degeneration (FTLD) represents a clinically, pathologically and genetically heterogenous neurodegenerative disorder, often complicated by neurological signs such as motor neuron-related li...

    Authors: Agnes A Luty, John BJ Kwok, Elizabeth M Thompson, Peter Blumbergs, William S Brooks, Clement T Loy, Carol Dobson-Stone, Peter K Panegyres, Jane Hecker, Garth A Nicholson, Glenda M Halliday and Peter R Schofield
    Citation: BMC Neurology 2008 8:32
  38. Recent consensus guidelines recommend pregabalin as a first-tier treatment for painful diabetic peripheral neuropathy (DPN). We evaluated the efficacy of pregabalin 600 mg/d (300 mg dosed BID) versus placebo f...

    Authors: Joseph C Arezzo, Julio Rosenstock, Linda LaMoreaux and Lynne Pauer
    Citation: BMC Neurology 2008 8:33
  39. Delirium is a common disorder in the early phase of stroke. Given the presumed cholinergic deficiency in delirium, we tested treatment with the acetylcholinesterase inhibitor rivastigmine.

    Authors: Annemarie W Oldenbeuving, Paul LM de Kort, Ben PW Jansen, L Jaap Kappelle and Gerwin Roks
    Citation: BMC Neurology 2008 8:34
  40. Processing stimuli in one sensory modality is known to result in suppression of other sensory-specific cortices. Additionally, behavioral experiments suggest that the primary consequence of paying attention to...

    Authors: Jennifer L Mozolic, David Joyner, Christina E Hugenschmidt, Ann M Peiffer, Robert A Kraft, Joseph A Maldjian and Paul J Laurienti
    Citation: BMC Neurology 2008 8:35
  41. Considering the costs of multiple sclerosis (MS), it is crucial that the health-related services supplied are in accordance with needs as they are perceived by people with MS (PwMS). Satisfaction with care is ...

    Authors: Charlotte Ytterberg, Sverker Johansson, Kristina Gottberg, Lotta Widén Holmqvist and Lena von Koch
    Citation: BMC Neurology 2008 8:36
  42. Detecting malingering or exaggeration of impairments in brain function after traumatic brain injury is of increasing importance in neuropsychological assessment. Lawyers involved in brain injury litigation cas...

    Authors: Jascha Rüsseler, Alexandra Brett, Ulrike Klaue, Michael Sailer and Thomas F Münte
    Citation: BMC Neurology 2008 8:37
  43. To reduce injection pain and improve satisfaction, a thinner (29-gauge [29G]), sharper (5-bevel) needle than the 27G/3-bevel needle used previously to inject interferon (IFN) beta-1a, 44 or 22 mcg subcutaneous...

    Authors: Amer Jaber, Gian B Bozzato, Lionel Vedrine, Wes A Prais, Julie Berube and Philippe E Laurent
    Citation: BMC Neurology 2008 8:38

Annual Journal Metrics

  • 2022 Citation Impact
    2.6 - 2-year Impact Factor
    2.9 - 5-year Impact Factor
    1.092 - SNIP (Source Normalized Impact per Paper)
    0.771 - SJR (SCImago Journal Rank)

    2023 Speed
    26 days submission to first editorial decision for all manuscripts (Median)
    154 days submission to accept (Median)

    2023 Usage 
    3,186,031 downloads
    2,601 Altmetric mentions 

Sign up for article alerts and news from this journal